
Por favor, tente outra busca
Nome | Título | Desde | Até |
---|---|---|---|
Ziad Bakri | Equity Research Analyst | 2016 | Agora |
Biografia | Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment ban | ||
Jason(Jay) Nogueira | Portfolio Manager | 2025 | 2025 |
Biografia | Jay Nogueira is the head of Global Equity Research, a member of the Global Equity Steering Committee, and chair of the Process and Innovation Subcommittee and the Equity Research Advisory Committee in the Equity Division. He is a co-portfolio manager of the US Structured Research Equity Strategy, cochairman of the US Structured Research Equity Strategy's Investment Advisory Committee, and a member of the portfolio oversight team. Additionally, Jay is a member of the oversight team for the International and Global Structured Research Equity Strategies. He is a vice president of T. Rowe Price Group, Inc. Jay's investment experience began in 2001, and he has been with T. Rowe Price since 2004, beginning as an investment analyst covering health care services in the U.S. Equity Division. He subsequently became associate portfolio manager for the Global Growth Equity Strategy. In 2015, Jay became the sector portfolio manager of the Global Consumer Equity Strategy, which he incepted that year as the sector team lead. He also had portfolio management responsibilities for the US Structured Research Equity Strategy, both as an analyst and as a sector portfolio manager. Most recently, Jay was director of equity research for North America in the U.S. Equity Division. Prior to T. Rowe Price, Jay was employed by Putnam Investments as a health care equity analyst. Jay also was a leveraged buyout analyst at J.W. Childs Associates and an investment banking analyst at Goldman, Sachs & Company prior to business school. Jay earned an S.B. in mechanical engineering from the Massachusetts Institute of Technology, where he was a member of Phi Beta Kappa, and an M.B.A., with high distinction, from Harvard Business School, where he was designated a Baker Scholar, a Siebel Scholar, and a Ford Scholar. Jay also has earned the Chartered Financial Analyst® designation. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. | ||
Taymour R. Tamaddon | Portfolio Manager | 2013 | 2016 |
Biografia | Taymour R. Tamaddon is a vice president of T. Rowe Price Group, Inc. and T. Rowe Price Associates, Inc. He is also a vice president of the T. Rowe Price Institutional International Funds, Inc., and the T. Rowe Price International Funds, Inc. He joined the firm in 2004 after serving as a summer intern with T. Rowe Price in 2003, covering the eye care industry. Prior to this, Taymour was employed by Amazon.com in the areas of finance and merchandizing. He was also a consultant with Booz Allen and Hamilton, specializing in the energy industry. | ||
Kris H. Jenner | Chairman | 2000 | 2013 |
Biografia | Mr. Jenner has been chairman of the committee since2000.He is a lead portfolio manager and a VP of T. Rowe Price Group. Dr. Jenner joined T. Rowe in 1997 as a health care sector analyst and now acts as its lead analyst for biotechnology and US pharmaceutical companies. He has also been portfolio manager for the Oxford Capital Group, where he managed a private hedge fund specializing in health care. Dr. Jenner graduated summa cum laude and as a member of Phi Beta Kappa from the University of Illinois with a B.S. in Chemistry. He received a D. Phil. from University of Oxford. | ||
Laurie Mundt | Research Analyst | 2007 | 2007 |
Biografia | Prior to joining Fidelity Investments in 2008 as a research analyst, Ms. Mundt served as a vice president for T. Rowe Price Group, which she joined in 2000. | ||
Brian Stansky | Vice President, Investment Analyst | 1998 | 2000 |
Biografia | Stansky is a vice president with T. Rowe Price Associates, his employer since 1989. He also serves as an investment analyst in the firm's equity research division. Previously, he worked as a financial analyst with Honeywell Information Systems. Stansky is a Chartered Financial Analyst. | ||
Joseph Klein | Vice President | 1995 | 1998 |
Biografia | Joseph Klein is a Portfolio Manager for the Hightower Equity SMA strategies. He is responsible for the quantitative modeling and leads portfolio construction decisions made throughout the investment process. Joe has seven years of investment related experience and was previously a Leveraged Finance Credit Analyst for Barclays, where he covered health care and industrial companies. Joe also spent time as a Restructuring Senior Associate for Ankura Consulting Group, where he advised the Government of Puerto Rico in 2017-2018. Joe graduated from New York University’s Stern School of Business. Joe holds the FINRA Series 7 & 63 licenses. Outside of work, Joe interests include real estate, softball, and urban gardening. He is a lifelong New Yorker. |
Tem certeza de que deseja bloquear %USER_NAME%?
Ao confirmar o bloqueio, você e %USER_NAME% não poderão ver o que cada um de vocês posta no Investing.com.
%USER_NAME% foi adicionado com êxito à sua Lista de bloqueios
Já que acabou de desbloquear esta pessoa, você deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou desse comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão